Exploring the structure activity relationships of novel trypsin inhibitor SFTI-1 with implications as cancer therapeutic

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A novel peptide isolated from sunflower seeds has recently been shown to interact with an enzyme implicated in the growth of cancers and in particular prostate cancer. The proposed research involves developing this peptide as a therapeutic by performing a thorough analysis of the important features involved in its exciting anti-cancer activity.

Funded Activity Details

Start Date: 01-01-2004

End Date: 01-01-2008

Funding Scheme: Early Career Fellowships

Funding Amount: $360,312.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oral and maxillofacial surgery

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Enzyme inhibitors as pharmacological agents | cancer